Compensation - Activity Associated with Restricted Stock Units (Detail) - USD ($)			12 Months Ended
	Jul. 12, 2023	Jul. 01, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of Units, Balance outstanding at beginning of period (in shares)			12,046,000	11,034,000	8,960,000
Number of Units, Granted (in shares)			68,732,000	7,125,000	6,319,000
Number of Units, Delivered			(15,078,000)	(4,858,000)	(3,135,000)
Number of Units, Forfeited (in shares)			(758,000)	(1,255,000)	(1,110,000)
Number of Units, Balance outstanding at end of period (in shares)			64,942,000	12,046,000	11,034,000	8,960,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-Average Grant Date Fair Value, Balance outstanding at beginning of period (in dollars per share)			$ 4.11	$ 3.87	$ 3.75
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)			4.12	4.27	4.23
Weighted-Average Grant Date Fair Value, Delivered (in dollars per share)			4.14	3.86	4.08
Weighted-Average Grant Date Fair Value, Forfeited (in dollars per share)			4.48	3.93	4.28
Weighted-Average Grant Date Fair Value, Balance outstanding at end of period (in dollars per share)			$ 4.11	$ 4.11	$ 3.87	$ 3.75
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Fair Value Outstanding [Roll Forward]
Fair Value, Balance outstanding at beginning of period			$ 49,486,000	$ 42,756,000	$ 33,582,000
Fair value of shares granted			283,418,000	30,406,000	26,716,000
Fair Value, Delivered	$ (3,986,600)		(62,494,000)	(18,743,000)	(12,792,000)
Fair Value, Forfeited			(3,395,000)	(4,933,000)	(4,750,000)
Fair Value, Balance outstanding at end of period			$ 267,015,000	$ 49,486,000	$ 42,756,000	$ 33,582,000
Weighted- Average Remaining Contractual Term (Years)			5 years 11 months 15 days	2 years 5 months 1 day	2 years 3 months 7 days	2 years 5 months 15 days
Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of Units, Balance outstanding at beginning of period (in shares)			0
Number of Units, Granted (in shares)		38,600,000	38,610,000
Number of Units, Delivered			(9,329,000)
Number of Units, Forfeited (in shares)			(1,328,000)
Number of Units, Balance outstanding at end of period (in shares)			27,953,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-Average Grant Date Fair Value, Balance outstanding at beginning of period (in dollars per share)			$ 0
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)			4.37
Weighted-Average Grant Date Fair Value, Delivered (in dollars per share)			5.12
Weighted-Average Grant Date Fair Value, Forfeited (in dollars per share)			2.62
Weighted-Average Grant Date Fair Value, Balance outstanding at end of period (in dollars per share)			$ 4.20	$ 0
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Fair Value Outstanding [Roll Forward]
Fair Value, Balance outstanding at beginning of period			$ 0
Fair value of shares granted			168,716,000
Fair Value, Delivered			(47,763,000)
Fair Value, Forfeited			(3,485,000)
Fair Value, Balance outstanding at end of period			$ 117,468,000	$ 0
Weighted- Average Remaining Contractual Term (Years)			2 years 6 months 18 days